5-azacytidine inhibits cell proliferation by reversing the abnormally high methylation of the hepaCAM gene through the downregulation of DNMT3A/3B expression in bladder cancer cells [28]. This evidence concerns the gene DNMT3A and urinary bladder carcinoma.